Kudos

Explore subjects

All stories
  • Arts and humanities
  • Business and management
  • Environmental research
  • Life sciences
  • Medical research
  • Physical sciences
  • Social sciences
  • Technology and engineering
  • About Kudos

  • Publishers
  • Pharma
  • Institutions and universities
  • Individual researchers and groups

  • Welcome pack and guides
  • Webinars and courses
  • Blog and news

  • Search Kudos

    Main menu

  • Home
  • Showcases on Kudos

  • What's new
  • Support
  • Log in
  • Sign up free
  • Discover

  • Showcases on Kudos
  • Subjects on Kudos

  • Arts and humanities
  • Business and management
  • Environmental research
  • Life sciences
  • Medical research
  • Physical sciences
  • Social sciences
  • Technology and engineering
  • Services and resources

  • About Kudos

  • Publishers
  • Pharma
  • Institutions and universities
  • Individual researchers and groups

  • Welcome pack and guides
  • Webinars and courses
  • Blog and news
  • Admin

    Log in Sign up free
    Nobuhiro Hata's profile pictureNH

    Dr. Nobuhiro Hata

    4 Stories

    Kyushu medical center

    Japan

    Medicine And Medical Sciences

    Kyushu medical center

    Japan

    Medicine And Medical Sciences

    All Stories

    1. An elderly case of malignant small cell glioma with hemorrhage coexistent with a calcified pilocytic astrocytoma component in the cerebellar hemisphere

      Article • Neuropathology, May 2018, Wiley

      Dr. Nobuhiro Hata

    2. Pediatric ganglioglioma with an H3 K27M mutation arising from the cervical spinal cord

      Article • Neuropathology, April 2018, Wiley

      Dr. Nobuhiro Hata

    3. Add-on bevacizumab can prevent early clinical deterioration and prolong survival in newly diagnosed partially resected glioblastoma patients with a poor performance status

      Article • OncoTargets and Therapy, January 2017, Dove Medical Press

      Dr. Nobuhiro Hata, MD, Phd Koji KI Iihara

    4. Deferred radiotherapy and upfront procarbazine–ACNU–vincristine administration for 1p19q codeleted oligodendroglial tumors are associated with favorable outcome without compromising patient performance, regardless of WHO grade

      Article • OncoTargets and Therapy, November 2016, Dove Medical Press

      Dr. Nobuhiro Hata, MD, Phd Koji KI Iihara

    Kudos
    • For researchers
    • For publishers
    • For universities
    • For pharma
    • For research groups
    • Research showcase
    • About Kudos
    • News
    • Careers
    • Engineering blog
    • Service status
    • User guide
    • Content and resources
    • FAQs
    • Contact us
    • Terms & conditions
    • Privacy policy
    • Cookie policy

    © 2025 Kudos Innovations Ltd. Kudos is registered in England – Registration No. 08642156. Registered Office: Kudos Innovations Ltd, 100 Liverpool Street, London, EC2M 2AT, UK